Skip to content
DataLookout
Menu

NCT07701304

Testing Warning Labels for Retail Cannabis Products Using a Discrete Choice Experiment

StatusCompleted
PhaseNot applicable
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Minor Trial completed Show 4 more changesShow less
    • Final enrollment: 509 participants (planned 450)
    • Primary completion date changed from estimate of Dec 31, 2026 to Jul 12, 2026
    • Study completion date changed from estimate of Dec 31, 2026 to Aug 12, 2026
    • Site details revised
  2. Notable Phase changed: Not specified → Not applicable
    • Interventions: Cannabis Packaging Discrete Choice Experiment (Behavioral) to Discrete choice experiment (DCE) survey-experiment (Behavioral)
    v3
  3. Notable Eligibility criteria expanded, about 5 words
    • Primary and study completion pushed from Sep 30, 2026 to Dec 31, 2026
    • Start date: May 20, 2026 to May 19, 2026
    v2
  4. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Risk perceptions about cannabis products
Timeframe: At the time of survey completion (approximately 15 minutes)
Cannabis product use intentions
Timeframe: At the time of survey completion (approximately 15 minutes)

Arms and interventions

Discrete choice experiment (DCE) cohortExperimental

Adult participants (21+) enrolled in this single-arm cohort will complete a computer-based discrete choice experiment during a single study visit (conducted online). They will review a series of hypothetical cannabis products and select their preferred options.

Behavioral: Discrete choice experiment (DCE) survey-experiment

Sites

1 site in 1 country

  • University of OKlahomaOklahoma City, Oklahoma, United States